speb/financial-data huggingface dataset:
Financial ratios for BLUEJET.NS — annual report dated 2025-03-31
Total revenue: 120409749.82464343
Gross profit: 66490998.36333878
Operating income: 42078676.64250643
Net income: 35679565.11573532
Capital expenditures: 9293663.783025485
Operating cash flow: 5350128.594809446
Depreciation & amortization: 2079611.8774842178
Net tangible assets: 132405658.17161562
Owner earnings: 28465513.210194055
Return on net tangible assets (%): 21.498713577103256
Capex to operating income (%): 22.08639749292245
Buffett classification: The Great
Stock price: 10.308087291399229
P/E ratio: 50.115429858506985
Shares outstanding: 173465425
Book value: 132465630.11456627
P/B ratio: 13.49857122480137
Market cap (USD): 1788096742.939666
Debt to equity: 0.017638166075521287
Current ratio: 3.9309084941013728
Quick ratio: 2.8995807070537345
Effective tax rate (%): 24.8451732213081
Interest coverage ratio: 3672.8673469387754
COGS to revenue (%): 44.779389991116375
R&D to revenue (%): 0.1506818060457191
SG&A to revenue (%): 3.077326368830614
Free cash flow (dilution-adjusted): -3988192.658405424
Buyback yield (%): 0
Retained earnings: 128409866.72901565
Inventory turnover: 1.747552325669511
Receivables turnover: 2.9467460869216926
Capitalized R&D asset: 263628.8942410907
ROCI (R&D-adjusted, %): 30.98482312795994
Rosenberg metric: 160.85575303214281
FCF margin (%): -3.3121841580217186
Revenue growth (%): 41.359184333128006
Rule of 40 score: 38.04700017510629
Financial ratios for BLUEJET.NS — quarterly report dated 2025-03-31
Total revenue: 39799509.00163666
Gross profit: 21857844.2833762
Operating income: 15784545.241992049
Net income: 12870586.85994856
Capital expenditures: 0
Depreciation & amortization: 578325.9293897591
Net tangible assets: 132405658.17161562
Owner earnings: 13448912.78933832
Return on net tangible assets (%): 10.157355036826834
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.308087291399229
P/E ratio: 34.73223020824267
Shares outstanding: 173465425
Book value: 132465630.11456627
P/B ratio: 13.49857122480137
Market cap (USD): 1788096742.939666
Debt to equity: 0.017638166075521287
Current ratio: 3.9309084941013728
Quick ratio: 2.8995807070537345
Effective tax rate (%): 25.21329782898133
Interest coverage ratio: 3971.205882352941
COGS to revenue (%): 45.080115730881644
Buyback yield (%): 0
Retained earnings: 128409866.72901565
Inventory turnover: 0.5815045240296449
Receivables turnover: 0.9739995937436523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.623468523377614
Revenue growth (%): 7.2422397387543604
Rule of 40 score: 7.2422397387543604
Financial ratios for BLUEJET.NS — quarterly report dated 2025-06-30
Total revenue: 41511584.3669553
Gross profit: 20110109.992979173
Operating income: 13491223.964427803
Net income: 10668148.841563305
Capital expenditures: 0
Depreciation & amortization: 666744.6758717529
Owner earnings: 11334893.517435057
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.25286683828692
P/E ratio: 50.7038852154224
Shares outstanding: 173465425
Market cap (USD): 1778517903.5718467
Effective tax rate (%): 25.79358619566987
Interest coverage ratio: 167.09565217391304
COGS to revenue (%): 51.55542651610393
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.301749966936114
Rule of 40 score: 4.301749966936114
Financial ratios for BLUEJET.NS — quarterly report dated 2025-12-31
Total revenue: 21434109.390665032
Gross profit: 11091121.75559764
Operating income: 4556867.550406595
Net income: 4474323.270580372
Capital expenditures: 0
Depreciation & amortization: 666481.0070179347
Owner earnings: 5140804.277598307
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.906204745460623
P/E ratio: 25.903904425230944
Shares outstanding: 173465425
Market cap (USD): 1024522316.3083438
Effective tax rate (%): 25.310076798631382
Interest coverage ratio: 120.66961651917403
COGS to revenue (%): 48.254804743937555
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -48.36595683462435
Rule of 40 score: -48.36595683462435
Financial ratios for BRK.B — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 9466000000
Buffett classification: The Gruesome
Stock price: 299
Shares outstanding: 1398308677
Market cap (USD): 418094294423
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRK.B — annual report dated 2022-12-31
Total revenue: 234121000000
Net income: -21998000000
Capital expenditures: 15464000000
Operating cash flow: 37350000000
Depreciation & amortization: 10899000000
Net tangible assets: 366118000000
Owner earnings: -26563000000
Return on net tangible assets (%): -7.255311129198782
Buffett classification: The Gruesome
Stock price: 308.9
Shares outstanding: 1398308677
Book value: 481681000000
P/B ratio: 0.8967294751615695
Market cap (USD): 431937550325.3
Debt to equity: 0.25482425090464433
COGS to revenue (%): 0
SG&A to revenue (%): 10.702158285672793
Free cash flow (dilution-adjusted): 21886000000
Buyback yield (%): 1.8183184106325117
Retained earnings: 511127000000
Receivables turnover: 4.848731490110801
Capitalized R&D asset: 0
FCF margin (%): 9.348157576637721
Rule of 40 score: 9.348157576637721
Financial ratios for BRK.B — annual report dated 2023-12-31
Total revenue: 439337000000
Net income: 97147000000
Capital expenditures: 19409000000
Operating cash flow: 49196000000
Depreciation & amortization: 12486000000
Net tangible assets: 440763000000
Owner earnings: 90224000000
Return on net tangible assets (%): 20.46995777776265
Buffett classification: The Gruesome
Stock price: 356.66
P/E ratio: 5.133671371620534
Shares outstanding: 1398308677
Book value: 570770000000
P/B ratio: 0.8737683703397516
Market cap (USD): 498720772738.82
Debt to equity: 0.22473325507647565
Effective tax rate (%): 19.156000865469434
COGS to revenue (%): 0
SG&A to revenue (%): 7.168756558177436
Free cash flow (dilution-adjusted): 29787000000
Buyback yield (%): 1.8389047541845327
Retained earnings: 607350000000
Receivables turnover: 8.570756925477955
Capitalized R&D asset: 0
FCF margin (%): 6.779988937876846
Revenue growth (%): 87.65382003323067
Rule of 40 score: 94.43380897110752
Financial ratios for BRK.B — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 460.26
Shares outstanding: 1398308677
Market cap (USD): 643585551676.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRK.B — quarterly report dated 2024-12-31
Total revenue: 101468000000
Net income: 19751000000
Capital expenditures: 5347000000
Operating cash flow: 4621000000
Depreciation & amortization: 3283000000
Net tangible assets: 530850000000
Owner earnings: 17687000000
Return on net tangible assets (%): 3.3318263162852033
Buffett classification: The Gruesome
Stock price: 453.28
P/E ratio: 8.022699573572982
Shares outstanding: 1398308677
Book value: 651655000000
P/B ratio: 0.972639444354083
Market cap (USD): 633825357110.5599
Debt to equity: 0.19145406695260528
Effective tax rate (%): 17.789802289281997
COGS to revenue (%): 0
SG&A to revenue (%): 10.067213308629322
Free cash flow (dilution-adjusted): -726000000
Buyback yield (%): 0
Retained earnings: 696218000000
Receivables turnover: 2.0968795205620996
Capitalized R&D asset: 0
FCF margin (%): -0.7154965112153585
Rule of 40 score: -0.7154965112153585
Financial ratios for BRK.B — annual report dated 2024-12-31
Total revenue: 424232000000
Net income: 89561000000
Capital expenditures: 18976000000
Operating cash flow: 30592000000
Depreciation & amortization: 12855000000
Net tangible assets: 530850000000
Owner earnings: 83440000000
Return on net tangible assets (%): 15.718187811999623
Buffett classification: The Gruesome
Stock price: 453.28
P/E ratio: 7.077024118874956
Shares outstanding: 1398308677
Book value: 651655000000
P/B ratio: 0.972639444354083
Market cap (USD): 633825357110.5599
Debt to equity: 0.19145406695260528
Effective tax rate (%): 18.85826628977314
COGS to revenue (%): 0
SG&A to revenue (%): 7.710639461426766
Free cash flow (dilution-adjusted): 11616000000
Buyback yield (%): 0.46037918288759866
Retained earnings: 696218000000
Receivables turnover: 8.766935317214301
Capitalized R&D asset: 0
FCF margin (%): 2.7381244224858095
Revenue growth (%): -3.4381351900704926
Rule of 40 score: -0.7000107675846832
Financial ratios for BRK.B — quarterly report dated 2025-03-31
Total revenue: 83290000000
Net income: 4672000000
Capital expenditures: 4281000000
Operating cash flow: 10903000000
Depreciation & amortization: 3265000000
Net tangible assets: 536133000000
Owner earnings: 3656000000
Return on net tangible assets (%): 0.6819203443921564
Buffett classification: The Gruesome
Stock price: 532.58
P/E ratio: 39.849702225848674
Shares outstanding: 1398308677
Book value: 656742000000
P/B ratio: 1.133947935713964
Market cap (USD): 744711235196.66
Debt to equity: 0.19174500793310006
Effective tax rate (%): 9.246309246309247
COGS to revenue (%): 0
SG&A to revenue (%): 11.487573538239884
Free cash flow (dilution-adjusted): 6622000000
Buyback yield (%): 0
Retained earnings: 700821000000
Receivables turnover: 1.6112744718718564
Capitalized R&D asset: 0
FCF margin (%): 7.9505342778244685
Revenue growth (%): -17.915007687152603
Rule of 40 score: -9.964473409328134
Financial ratios for BRK.B — quarterly report dated 2025-06-30
Total revenue: 98879000000
Net income: 12457000000
Capital expenditures: 4858000000
Operating cash flow: 10085000000
Depreciation & amortization: 3329000000
Net tangible assets: 549659000000
Owner earnings: 10928000000
Return on net tangible assets (%): 1.988141738787139
Buffett classification: The Gruesome
Stock price: 485.77
P/E ratio: 18.418015347784436
Shares outstanding: 1398308677
Book value: 670276000000
P/B ratio: 1.013398071878286
Market cap (USD): 679256406026.2899
Debt to equity: 0.18950402520752646
Effective tax rate (%): 15.545762711864406
COGS to revenue (%): 0
SG&A to revenue (%): 9.929307537495323
Free cash flow (dilution-adjusted): 5227000000
Buyback yield (%): 0
Retained earnings: 713191000000
Receivables turnover: 1.9090084176384277
Capitalized R&D asset: 0
FCF margin (%): 5.286258962974949
Revenue growth (%): 18.716532596950415
Rule of 40 score: 24.002791559925363
Financial ratios for BRK.B — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 502.74
P/E ratio: 19.061434497694684
Shares outstanding: 1398308677
Market cap (USD): 702985704274.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRK.B — quarterly report dated 2025-12-31
Total revenue: 111442000000
Net income: 19267000000
Capital expenditures: 6202000000
Operating cash flow: 11192000000
Depreciation & amortization: 3549000000
Net tangible assets: 600543000000
Owner earnings: 16614000000
Return on net tangible assets (%): 2.766496320829649
Buffett classification: The Gruesome
Stock price: 502.65
P/E ratio: 19.31145885520524
Shares outstanding: 1398308677
Book value: 719703000000
P/B ratio: 0.9765970914308401
Market cap (USD): 702859856494.0499
Debt to equity: 0.17935314984097606
Effective tax rate (%): 21.217697088649
COGS to revenue (%): 0
SG&A to revenue (%): 8.858419626352722
Free cash flow (dilution-adjusted): 4990000000
Buyback yield (%): 0
Retained earnings: 763186000000
Receivables turnover: 2.2874912763249724
Capitalized R&D asset: 0
FCF margin (%): 4.477665512104951
Rule of 40 score: 4.477665512104951
Financial ratios for BRK.B — annual report dated 2025-12-31
Total revenue: 410522000000
Net income: 67260000000
Capital expenditures: 20927000000
Operating cash flow: 45969000000
Depreciation & amortization: 13476000000
Net tangible assets: 600543000000
Owner earnings: 59809000000
Return on net tangible assets (%): 9.959153632629137
Buffett classification: The Gruesome
Stock price: 502.65
P/E ratio: 10.44989379265611
Shares outstanding: 1398308677
Book value: 719703000000
P/B ratio: 0.9765970914308401
Market cap (USD): 702859856494.0499
Debt to equity: 0.17935314984097606
Effective tax rate (%): 18.432190543179033
COGS to revenue (%): 0
SG&A to revenue (%): 9.115224031842386
Free cash flow (dilution-adjusted): 25042000000
Buyback yield (%): 0
Retained earnings: 763186000000
Receivables turnover: 8.42649534053122
Capitalized R&D asset: 0
FCF margin (%): 6.1000384875841
Revenue growth (%): -3.2317222651756587
Rule of 40 score: 2.868316222408441
Financial ratios for CBHD.DE — annual report dated 2021-09-30
Total revenue: 3030577223.0889235
Gross profit: 2076911076.4430578
Operating income: 991419656.7862715
Net income: 752730109.2043681
Capital expenditures: 137753510.14040563
Operating cash flow: 825273010.9204367
Depreciation & amortization: 123556942.27769111
Net tangible assets: 704680187.2074883
Owner earnings: 738533541.3416536
Return on net tangible assets (%): 104.80407350011068
Capex to operating income (%): 13.894571203776554
Buffett classification: The Great
Stock price: 52.67441860465116
P/E ratio: 14.511078119028317
Shares outstanding: 207366796
Book value: 1274258970.3588142
P/B ratio: 8.571982360958819
Market cap (USD): 10922925417.209301
Debt to equity: 0.3410871694417238
Current ratio: 1.1076971808679126
Quick ratio: 0.7231548938866013
Effective tax rate (%): 22.589443285737204
Interest coverage ratio: 254.2
COGS to revenue (%): 31.468135488520538
R&D to revenue (%): 3.8865438072686094
SG&A to revenue (%): 32.15793266755894
Free cash flow (dilution-adjusted): 518564742.58970356
Buyback yield (%): 0.7141229766332508
Retained earnings: 843369734.7893915
Inventory turnover: 2.517710049423394
Receivables turnover: 6.047945205479452
Capitalized R&D asset: 117784711.38845554
ROCI (R&D-adjusted, %): 66.70232769240745
FCF margin (%): 17.111088232266034
Rule of 40 score: 17.111088232266034
Financial ratios for CBHD.DE — annual report dated 2022-09-30
Total revenue: 2982694848.084544
Gross profit: 2051387054.1611624
Operating income: 912813738.4412153
Net income: 621664464.993395
Capital expenditures: 121003963.01188903
Operating cash flow: 673579920.7397622
Depreciation & amortization: 122853368.56010568
Net tangible assets: -1912153236.4597094
Owner earnings: 623513870.5416117
Return on net tangible assets (%): -32.60794473229707
Capex to operating income (%): 13.256150506512302
Buffett classification: The Great
Stock price: 39.568627450980394
P/E ratio: 13.198791242981258
Shares outstanding: 207366796
Book value: 1095376486.1294584
P/B ratio: 7.490775637900362
Market cap (USD): 8205219496.627451
Debt to equity: 2.2561505065123004
Current ratio: 1.1957470010905125
Quick ratio: 0.7613140676117774
Effective tax rate (%): 23.192426962624445
Interest coverage ratio: 40.174418604651166
COGS to revenue (%): 31.223703441250716
R&D to revenue (%): 3.835422295052925
SG&A to revenue (%): 34.55423180831747
Free cash flow (dilution-adjusted): 523645970.9379128
Buyback yield (%): 0.9965625580649667
Retained earnings: 711492734.4782034
Inventory turnover: 2.2121117037966735
Receivables turnover: 5.730710659898477
Capitalized R&D asset: 193314699.8270948
ROCI (R&D-adjusted, %): 22.77272958728018
Rosenberg metric: -0.21670063950589338
FCF margin (%): 17.556136232782674
Revenue growth (%): -1.5799754132506494
Rule of 40 score: 15.976160819532025
Financial ratios for CBHD.DE — annual report dated 2023-09-30
Total revenue: 3470254957.5070825
Gross profit: 2312747875.354108
Operating income: 969546742.2096318
Net income: 677478753.5410765
Capital expenditures: 143342776.20396602
Operating cash flow: 598583569.4050992
Depreciation & amortization: 151416430.59490085
Net tangible assets: -1976770538.243626
Owner earnings: 685552407.9320114
Return on net tangible assets (%): -34.68042419031241
Capex to operating income (%): 14.784514243973703
Buffett classification: The Great
Stock price: 47.968421052631584
P/E ratio: 14.682464550912377
Shares outstanding: 207366796
Book value: 2450283286.1189804
P/B ratio: 4.059554190821082
Market cap (USD): 9947057782.86316
Debt to equity: 1.1311058442684547
Current ratio: 0.6092207712586598
Quick ratio: 0.39329286984243766
Effective tax rate (%): 20.61410788381743
Interest coverage ratio: 10.72884012539185
COGS to revenue (%): 33.35510204081633
R&D to revenue (%): 3.559183673469388
SG&A to revenue (%): 35.236734693877544
Free cash flow (dilution-adjusted): 422804532.5779037
Buyback yield (%): 0
Retained earnings: 2072521246.4589236
Inventory turnover: 2.3202725724020445
Receivables turnover: 5.677867902665121
Capitalized R&D asset: 239028994.57542026
ROCI (R&D-adjusted, %): 20.515330407599915
Rosenberg metric: 2.284643667933715
FCF margin (%): 12.183673469387754
Revenue growth (%): 16.346295355545486
Rule of 40 score: 28.529968824933242
Financial ratios for CBHD.DE — annual report dated 2024-09-30
Total revenue: 4046407185.6287427
Gross profit: 2734880239.5209584
Operating income: 1090718562.8742516
Net income: 756287425.1497006
Capital expenditures: 172305389.2215569
Operating cash flow: 414071856.28742516
Depreciation & amortization: 193113772.45508984
Net tangible assets: -1854790419.1616766
Owner earnings: 777095808.3832335
Return on net tangible assets (%): -41.896690879741726
Capex to operating income (%): 15.797419709031018
Buffett classification: The Great
Stock price: 73.15555555555555
P/E ratio: 20.058555333182717
Shares outstanding: 207366796
Book value: 2685928143.712575
P/B ratio: 5.647966867865294
Market cap (USD): 15170033165.155554
Debt to equity: 1.2612306320365623
Current ratio: 1.0235201881615055
Quick ratio: 0.6636613092904744
Effective tax rate (%): 21.00078186082877
Interest coverage ratio: 9.164779874213837
COGS to revenue (%): 32.412134665186834
R&D to revenue (%): 3.3777284498705145
SG&A to revenue (%): 37.25120236773955
Free cash flow (dilution-adjusted): 212574850.2994012
Buyback yield (%): 0
Retained earnings: 2304041916.167665
Inventory turnover: 2.385893246187364
Receivables turnover: 5.781818181818181
Capitalized R&D asset: 257181839.03802785
ROCI (R&D-adjusted, %): 18.60439372594602
Rosenberg metric: 3.417723040158217
FCF margin (%): 5.253422123566407
Revenue growth (%): 16.602590736893553
Rule of 40 score: 21.856012860459963
Financial ratios for CBHD.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 73.15555555555555
Shares outstanding: 207366796
Market cap (USD): 15170033165.155554
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBHD.DE — quarterly report dated 2024-12-31
Total revenue: 979916317.9916319
Gross profit: 662482566.2482567
Operating income: 266666666.66666666
Net income: 145606694.56066945
Capital expenditures: 38214783.82147838
Operating cash flow: 279916317.9916318
Depreciation & amortization: 45746164.574616455
Net tangible assets: -2117015341.7015343
Owner earnings: 153138075.31380755
Return on net tangible assets (%): -7.233678107912247
Capex to operating income (%): 14.330543933054393
Buffett classification: The Great
Stock price: 72.66666666666667
P/E ratio: 25.872185836187743
Shares outstanding: 207366796
Book value: 2156345885.634589
P/B ratio: 6.9880504528762675
Market cap (USD): 15068653842.666668
Debt to equity: 1.6012547700666186
Current ratio: 0.8120642381511947
Quick ratio: 0.5243243243243243
Effective tax rate (%): 40.983606557377044
Interest coverage ratio: 9.372549019607842
COGS to revenue (%): 32.39396527184743
R&D to revenue (%): 3.1169940222032446
SG&A to revenue (%): 37.346996868773125
Free cash flow (dilution-adjusted): 236959553.69595537
Buyback yield (%): 0
Retained earnings: 2303765690.3765693
Inventory turnover: 0.6196569561666213
Receivables turnover: 1.524408765458885
Capitalized R&D asset: 30543933.054393306
ROCI (R&D-adjusted, %): 5.749888243182834
FCF margin (%): 24.181611158553938
Rule of 40 score: 24.181611158553938
Financial ratios for CBHD.DE — quarterly report dated 2025-03-31
Total revenue: 1005805515.2394775
Gross profit: 686211901.3062409
Operating income: 274455732.946299
Net income: 132365747.46008709
Capital expenditures: 40493468.79535559
Operating cash flow: 107692307.6923077
Depreciation & amortization: 49927431.059506536
Net tangible assets: -2071117561.6835995
Owner earnings: 141799709.72423804
Return on net tangible assets (%): -6.846531184302733
Capex to operating income (%): 14.754098360655737
Buffett classification: The Great
Stock price: 69.14130434782608
P/E ratio: 27.079533468794214
Shares outstanding: 207366796
Book value: 2458925979.6806965
P/B ratio: 5.830842763201588
Market cap (USD): 14337610753.869564
Debt to equity: 1.4321803801204112
Current ratio: 0.9544086805872162
Quick ratio: 0.6081882009665359
Effective tax rate (%): 38.83299798792756
Interest coverage ratio: 5.984177215189874
COGS to revenue (%): 31.774891774891778
R&D to revenue (%): 3.448773448773449
SG&A to revenue (%): 37.89321789321789
Free cash flow (dilution-adjusted): 62699564.58635704
Buyback yield (%): 0
Retained earnings: 2363570391.8722787
Inventory turnover: 0.5799315248880695
Receivables turnover: 1.4583333333333333
Capitalized R&D asset: 55152388.702321604
ROCI (R&D-adjusted, %): 5.134666414019982
Rosenberg metric: 0.7768919286107167
FCF margin (%): 6.233766233766234
Revenue growth (%): 2.641980419400132
Rule of 40 score: 8.875746653166367
Financial ratios for CBHD.DE — quarterly report dated 2025-06-30
Total revenue: 1094025157.2327044
Gross profit: 739779874.2138364
Operating income: 301100628.9308176
Net income: 126572327.04402515
Capital expenditures: 59905660.37735849
Operating cash flow: 256446540.88050312
Depreciation & amortization: 53930817.61006289
Net tangible assets: -2117610062.8930817
Owner earnings: 120597484.27672955
Return on net tangible assets (%): -5.6949806949806945
Capex to operating income (%): 19.89556135770235
Buffett classification: The Great
Stock price: 65.8
P/E ratio: 33.728616015338964
Shares outstanding: 207366796
Book value: 2586163522.012579
P/B ratio: 5.276052755620622
Market cap (USD): 13644735176.8
Debt to equity: 1.4722154669260696
Current ratio: 1.0002842793518432
Quick ratio: 0.6423765753814081
Effective tax rate (%): 40.01490312965723
Interest coverage ratio: 3.9081632653061225
COGS to revenue (%): 32.37999425122162
R&D to revenue (%): 3.434895084794481
SG&A to revenue (%): 37.050876688703646
Free cash flow (dilution-adjusted): 190723270.44025156
Buyback yield (%): 0
Retained earnings: 2643553459.119497
Inventory turnover: 0.596505162827641
Receivables turnover: 1.4529129254541657
Capitalized R&D asset: 70899043.14258936
ROCI (R&D-adjusted, %): 5.1247973435356
Rosenberg metric: 1.5442817294281719
FCF margin (%): 17.4331704512791
Revenue growth (%): 8.77104377104377
Rule of 40 score: 26.204214222322868
Financial ratios for CBHD.DE — quarterly report dated 2025-12-31
Total revenue: 1107389937.106918
Gross profit: 744496855.3459119
Operating income: 290880503.1446541
Net income: 219654088.05031446
Capital expenditures: 58176100.628930815
Operating cash flow: 351100628.9308176
Depreciation & amortization: 54245283.018867925
Net tangible assets: -2574213836.4779873
Owner earnings: 215723270.4402516
Return on net tangible assets (%): -8.3801612509162
Capex to operating income (%): 20
Buffett classification: The Great
Stock price: 77.85882352941178
P/E ratio: 25.86569102392075
Shares outstanding: 207366796
Book value: 2170440251.5723267
P/B ratio: 7.438737262602556
Market cap (USD): 16145334775.623533
Debt to equity: 1.8180237612286296
Current ratio: 1.2989404641775986
Quick ratio: 0.8121846619576186
Effective tax rate (%): 21.99888330541597
Interest coverage ratio: 11.28048780487805
COGS to revenue (%): 32.77012636660515
R&D to revenue (%): 3.5070282550049696
SG&A to revenue (%): 37.54082067300866
Free cash flow (dilution-adjusted): 286006289.3081761
Buyback yield (%): 0
Retained earnings: 2363522012.578616
Inventory turnover: 0.5980824047680746
Receivables turnover: 1.5654589908868637
Capitalized R&D asset: 75461175.61683598
ROCI (R&D-adjusted, %): 4.501945804639142
Rosenberg metric: 0.12552301255230014
FCF margin (%): 25.827062331392874
Revenue growth (%): 1.2216154067260578
Rule of 40 score: 27.048677738118933
Financial ratios for CBZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.12
Shares outstanding: 53648732
Market cap (USD): 2098738395.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBZ — annual report dated 2022-12-31
Total revenue: 1411979000
Gross profit: 223367000
Operating income: 168344000
Net income: 105354000
Capital expenditures: 8641000
Operating cash flow: 126132000
Depreciation & amortization: 32895000
Net tangible assets: -238250000
Owner earnings: 129608000
Return on net tangible assets (%): -54.400000000000006
Capex to operating income (%): 5.132942070997482
Buffett classification: The Great
Stock price: 46.85
P/E ratio: 23.85712069973613
Shares outstanding: 53648732
Book value: 713452000
P/B ratio: 3.522932298458761
Market cap (USD): 2513443094.2000003
Debt to equity: 0.6650286214069061
Current ratio: 1.1093252043785506
Quick ratio: 1.1093252043785506
Effective tax rate (%): 25.531719385050362
Interest coverage ratio: 20.940913048886678
COGS to revenue (%): 84.18057209066141
SG&A to revenue (%): 3.896870987458029
Free cash flow (dilution-adjusted): 102802000
Buyback yield (%): 5.165304927714006
Retained earnings: 734116000
Receivables turnover: 4.221188168539125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.317400017706664
FCF margin (%): 7.2807031832626405
Rule of 40 score: 7.2807031832626405
Financial ratios for CBZ — annual report dated 2023-12-31
Total revenue: 1591194000
Gross profit: 223204000
Operating income: 165239000
Net income: 120968000
Capital expenditures: 23052000
Operating cash flow: 153507000
Depreciation & amortization: 36269000
Net tangible assets: -216986000
Owner earnings: 134185000
Return on net tangible assets (%): -61.84039523287217
Capex to operating income (%): 13.950701710855185
Buffett classification: The Great
Stock price: 62.59
P/E ratio: 27.758366972091796
Shares outstanding: 53648732
Book value: 791618000
P/B ratio: 4.24178598248145
Market cap (USD): 3357874135.88
Debt to equity: 0.6960604736122726
Current ratio: 1.1968350585344223
Quick ratio: 1.1968350585344223
Effective tax rate (%): 27.260482372536877
Interest coverage ratio: 8.208186379216134
COGS to revenue (%): 85.97254640226146
SG&A to revenue (%): 3.6428619011886676
Free cash flow (dilution-adjusted): 118169000
Buyback yield (%): 2.1985934258566955
Retained earnings: 855084000
Receivables turnover: 4.185678360234854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.788152285967417
FCF margin (%): 7.426435745735592
Revenue growth (%): 12.692469222275967
Rule of 40 score: 20.11890496801156
Financial ratios for CBZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.29
Shares outstanding: 53648732
Market cap (USD): 3610023176.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 81.83
Shares outstanding: 53648732
Market cap (USD): 4390075739.559999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBZ — annual report dated 2024-12-31
Total revenue: 1813472000
Gross profit: 182469000
Operating income: 73716000
Net income: 41038000
Capital expenditures: 12914000
Operating cash flow: 123692000
Depreciation & amortization: 48060000
Net tangible assets: -1165487000
Owner earnings: 76184000
Return on net tangible assets (%): -6.536666646646423
Capex to operating income (%): 17.51858483911227
Buffett classification: The Great
Stock price: 81.83
P/E ratio: 106.97586967103659
Shares outstanding: 53648732
Book value: 1779983000
P/B ratio: 2.4663582402528563
Market cap (USD): 4390075739.559999
Debt to equity: 1.0298227567341935
Current ratio: 1.184079954434813
Quick ratio: 1.184079954434813
Effective tax rate (%): 29.00859757468819
Interest coverage ratio: 2.1442159457808545
COGS to revenue (%): 89.93814075982425
SG&A to revenue (%): 5.996949497979566
Free cash flow (dilution-adjusted): 96942000
Buyback yield (%): 0.2621367074900034
Retained earnings: 896122000
Receivables turnover: 3.390567215971342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9578861649988406
FCF margin (%): 5.3456573909054015
Revenue growth (%): 13.969258305398336
Rule of 40 score: 19.314915696303736
Financial ratios for CBZ — quarterly report dated 2025-03-31
Total revenue: 838014000
Gross profit: 228102000
Operating income: 200032000
Net income: 122773000
Capital expenditures: 5177000
Operating cash flow: -88266000
Depreciation & amortization: 24791000
Net tangible assets: -991824000
Owner earnings: 142387000
Return on net tangible assets (%): -14.356075271419122
Capex to operating income (%): 2.588085906254999
Buffett classification: The Great
Stock price: 75.86
P/E ratio: 8.287230925203424
Shares outstanding: 53648732
Book value: 1914701000
P/B ratio: 2.1255500516895327
Market cap (USD): 4069792809.52
Debt to equity: 1.0187193718497038
Current ratio: 1.5192974003996589
Quick ratio: 1.5192974003996589
Effective tax rate (%): 28.996009484703023
Interest coverage ratio: 7.95166163141994
COGS to revenue (%): 72.78064566940408
SG&A to revenue (%): 3.349586045101872
Free cash flow (dilution-adjusted): -97763000
Buyback yield (%): 0.18563598575159537
Retained earnings: 1018895000
Receivables turnover: 1.1394946602377398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.095791931340093
FCF margin (%): -11.666034218998728
Rule of 40 score: -11.666034218998728
Financial ratios for CBZ — quarterly report dated 2025-06-30
Total revenue: 683496000
Gross profit: 87909000
Operating income: 60272000
Net income: 41942000
Capital expenditures: 7948000
Operating cash flow: 113146000
Depreciation & amortization: 25067000
Net tangible assets: -1008115000
Owner earnings: 59061000
Return on net tangible assets (%): -5.858557803425205
Capex to operating income (%): 13.186886116272897
Buffett classification: The Great
Stock price: 71.71
P/E ratio: 23.356406955772087
Shares outstanding: 53648732
Book value: 1891843000
P/B ratio: 2.0335464262732157
Market cap (USD): 3847150571.72
Debt to equity: 1.0372483340319467
Current ratio: 1.603854091090963
Quick ratio: 1.603854091090963
Effective tax rate (%): 27.409612488966577
Interest coverage ratio: 2.162844942046148
COGS to revenue (%): 87.13832999754206
SG&A to revenue (%): 4.043476479745309
Free cash flow (dilution-adjusted): 97279000
Buyback yield (%): 1.8591422058124114
Retained earnings: 1060837000
Receivables turnover: 1.0110079964026542
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.531436214380743
FCF margin (%): 14.23256317520512
Revenue growth (%): -18.438594104633097
Rule of 40 score: -4.2060309294279765
Financial ratios for CBZ — quarterly report dated 2025-09-30
Total revenue: 693818000
Gross profit: 90129000
Operating income: 58864000
Net income: 30146000
Capital expenditures: 1910000
Operating cash flow: 23966000
Depreciation & amortization: 24455000
Net tangible assets: -1013928000
Owner earnings: 52691000
Return on net tangible assets (%): -5.1967200826883175
Capex to operating income (%): 3.244767599891275
Buffett classification: The Great
Stock price: 52.96
P/E ratio: 14.580838888848975
Shares outstanding: 53648732
Book value: 1871799000
P/B ratio: 1.5179177073606729
Market cap (USD): 2841236846.7200003
Debt to equity: 1.0446559700053264
Current ratio: 1.5666550839177946
Quick ratio: 1.5666550839177946
Effective tax rate (%): 25.392268474978962
Interest coverage ratio: 2.1052932761087266
COGS to revenue (%): 87.00970571533169
SG&A to revenue (%): 4.506224975425832
Free cash flow (dilution-adjusted): 14723000
Buyback yield (%): 1.9875850922175946
Retained earnings: 1090983000
Receivables turnover: 0.9642334001339719
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5080244454492704
FCF margin (%): 2.1220262374282592
Revenue growth (%): 1.5101770895513653
Rule of 40 score: 3.6322033269796243
Financial ratios for CBZ — quarterly report dated 2025-12-31
Total revenue: 542663000
Gross profit: -50747000
Operating income: -85158000
Net income: -79417000
Capital expenditures: 1924000
Operating cash flow: 143639000
Depreciation & amortization: 23957000
Net tangible assets: -1107723000
Owner earnings: -57384000
Buffett classification: The Gruesome
Stock price: 50.45
P/E ratio: 23.444947588441153
Shares outstanding: 53648732
Book value: 1762067000
P/B ratio: 1.5360247535422886
Market cap (USD): 2706578529.4
Debt to equity: 1.0377034471447453
Current ratio: 1.222480063730808
Quick ratio: 1.222480063730808
Interest coverage ratio: -3.2463403476669717
COGS to revenue (%): 109.35147596206116
SG&A to revenue (%): 6.34113621160831
Free cash flow (dilution-adjusted): 135283000
Buyback yield (%): 1.195937958141404
Retained earnings: 1011566000
Receivables turnover: 0.976021367098625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3178968375588673
FCF margin (%): 24.929468196652437
Revenue growth (%): -21.785972690244414
Rule of 40 score: 3.1434955064080228
Financial ratios for CBZ — annual report dated 2025-12-31
Total revenue: 2757991000
Gross profit: 355393000
Operating income: 234010000
Net income: 115444000
Capital expenditures: 16959000
Operating cash flow: 192485000
Depreciation & amortization: 98270000
Net tangible assets: -1107723000
Owner earnings: 196755000
Return on net tangible assets (%): -17.762112008146442
Capex to operating income (%): 7.247126191188411
Buffett classification: The Great
Stock price: 50.45
P/E ratio: 23.444947588441153
Shares outstanding: 53648732
Book value: 1762067000
P/B ratio: 1.5360247535422886
Market cap (USD): 2706578529.4
Debt to equity: 1.0377034471447453
Current ratio: 1.222480063730808
Quick ratio: 1.222480063730808
Effective tax rate (%): 28.22209096278795
Interest coverage ratio: 2.182623700041972
COGS to revenue (%): 87.11406237366258
SG&A to revenue (%): 4.401138364846005
Free cash flow (dilution-adjusted): 149522000
Buyback yield (%): 6.204142912388537
Retained earnings: 1011566000
Receivables turnover: 4.960460076079821
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.369466626237706
FCF margin (%): 5.421410004601175
Revenue growth (%): 52.08346199996471
Rule of 40 score: 57.50487200456589
Financial ratios for CEF.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.68503937007874
Shares outstanding: 184927470
Market cap (USD): 3270449587.5590553
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEF.TO — annual report dated 2022-12-31
Total revenue: 5992647.058823529
Net income: 3475735.2941176468
Capital expenditures: 0
Operating cash flow: -13102205.88235294
Net tangible assets: 2939945588.235294
Owner earnings: 3475735.2941176468
Return on net tangible assets (%): 0.11822447694360089
Buffett classification: The Gruesome
Stock price: 17.816176470588236
P/E ratio: 947.9146600592343
Shares outstanding: 184927470
Book value: 2939945588.235294
P/B ratio: 1.1206671487267423
Market cap (USD): 3294700439.779412
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 29.153374233128837
Free cash flow (dilution-adjusted): -13102205.88235294
Buyback yield (%): 0.10600803085628538
Retained earnings: 658809558.8235294
Capitalized R&D asset: 0
FCF margin (%): -218.63803680981596
Rule of 40 score: -218.63803680981596
Financial ratios for CEF.TO — annual report dated 2023-12-31
Total revenue: 237083333.3333333
Net income: 233739393.93939394
Capital expenditures: 0
Operating cash flow: -15219696.969696969
Net tangible assets: 3204647727.272727
Owner earnings: 233739393.93939394
Return on net tangible assets (%): 7.293762492213605
Buffett classification: The Gruesome
Stock price: 19.21969696969697
P/E ratio: 15.20603726599165
Shares outstanding: 184927470
Book value: 3204647727.272727
P/B ratio: 1.1090922426589223
Market cap (USD): 3554249934.772727
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.9279437609841827
Free cash flow (dilution-adjusted): -15219696.969696969
Buyback yield (%): 0.030714403508499244
Retained earnings: 895580303.030303
Capitalized R&D asset: 0
FCF margin (%): -6.419555839590989
Revenue growth (%): 3856.2372188139057
Rule of 40 score: 3849.8176629743148
Financial ratios for CEF.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.548148148148147
Shares outstanding: 184927470
Market cap (USD): 4539626930.222222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEF.TO — annual report dated 2024-12-31
Total revenue: 713900000
Net income: 711170629.3706294
Capital expenditures: 0
Operating cash flow: -15556643.356643358
Net tangible assets: 3505246153.846154
Owner earnings: 711170629.3706294
Return on net tangible assets (%): 20.288750009476306
Buffett classification: The Gruesome
Stock price: 23.90909090909091
P/E ratio: 6.217140457179829
Shares outstanding: 184927470
Book value: 3505246153.846154
P/B ratio: 1.2613800850952277
Market cap (USD): 4421447691.818182
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.2629112028187529
Free cash flow (dilution-adjusted): -15556643.356643358
Buyback yield (%): 0.09159104962712016
Retained earnings: 1477303496.5034966
Capitalized R&D asset: 0
FCF margin (%): -2.1791067875953716
Revenue growth (%): 201.11775043936734
Rule of 40 score: 198.93864365177197
Financial ratios for CEF.TO — quarterly report dated 2025-03-31
Total revenue: 640991608.3916085
Net income: 640218881.1188811
Capital expenditures: 0
Operating cash flow: -5495804.195804196
Net tangible assets: 4030700699.3006997
Owner earnings: 640218881.1188811
Return on net tangible assets (%): 15.88356290582317
Buffett classification: The Gruesome
Stock price: 28.53846153846154
P/E ratio: 2.060836397380485
Shares outstanding: 184927470
Book value: 4030700699.3006997
P/B ratio: 1.3093369822561174
Market cap (USD): 5277545490
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.08367716976974049
Free cash flow (dilution-adjusted): -5495804.195804196
Buyback yield (%): 0.03961896860711078
Retained earnings: 2061290909.0909092
Capitalized R&D asset: 0
FCF margin (%): -0.8573909742117217
Rule of 40 score: -0.8573909742117217
Financial ratios for CEF.TO — quarterly report dated 2025-06-30
Total revenue: 239429927.00729924
Net income: 238552554.74452552
Capital expenditures: 0
Operating cash flow: -5764963.503649634
Net tangible assets: 4426441605.839416
Owner earnings: 238552554.74452552
Return on net tangible assets (%): 5.389262436667505
Buffett classification: The Gruesome
Stock price: 29.912408759124084
P/E ratio: 5.7970727659515875
Shares outstanding: 184927470
Book value: 4426441605.839416
P/B ratio: 1.2496778600068434
Market cap (USD): 5531626073.430656
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.22651126916428624
Free cash flow (dilution-adjusted): -5764963.503649634
Buyback yield (%): 0.006861672115161971
Retained earnings: 2379710218.978102
Capitalized R&D asset: 0
FCF margin (%): -2.407787353781336
Revenue growth (%): -62.64694827938816
Rule of 40 score: -65.0547356331695
Financial ratios for CEF.TO — quarterly report dated 2025-09-30
Total revenue: 896758992.8057555
Net income: 895871942.4460433
Capital expenditures: 0
Operating cash flow: -4042446.0431654677
Net tangible assets: 5258623741.0071945
Owner earnings: 895871942.4460433
Return on net tangible assets (%): 17.036243446359506
Buffett classification: The Gruesome
Stock price: 36.74820143884892
P/E ratio: 3.8293620015140273
Shares outstanding: 184927470
Book value: 5258623741.0071945
P/B ratio: 1.2923061724577936
Market cap (USD): 6795751919.136691
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.06634603428012147
Free cash flow (dilution-adjusted): -4042446.0431654677
Buyback yield (%): 0
Retained earnings: 3241341726.6187053
Capitalized R&D asset: 0
FCF margin (%): -0.450783998331321
Revenue growth (%): 274.5392249058393
Rule of 40 score: 274.088440907508
Financial ratios for CEF.TO — annual report dated 2025-12-31
Total revenue: 486798175.1824817
Net income: 3181640145.985401
Capital expenditures: 0
Operating cash flow: -21800729.9270073
Net tangible assets: 6616795620.437956
Owner earnings: 3181640145.985401
Return on net tangible assets (%): 48.08430437473318
Buffett classification: The Gruesome
Stock price: 45.85401459854014
P/E ratio: 2.6651872996230423
Shares outstanding: 184927470
Book value: 6616795620.437956
P/B ratio: 1.2815367733074754
Market cap (USD): 8479666909.051094
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.39255465663837963
Free cash flow (dilution-adjusted): -21800729.9270073
Buyback yield (%): 0.05568494447793558
Retained earnings: 4590145985.40146
Capitalized R&D asset: 0
FCF margin (%): -4.47839187540813
Revenue growth (%): -31.811433648622817
Rule of 40 score: -36.289825524030945
Financial ratios for CEF.TO — quarterly report dated 2025-12-31
Total revenue: 208857882.46715328
Net income: 1365879562.0437956
Capital expenditures: 0
Operating cash flow: -6197810.218978101
Net tangible assets: 6616795620.437956
Owner earnings: 1365879562.0437956
Return on net tangible assets (%): 20.64261374229041
Buffett classification: The Gruesome
Stock price: 45.85401459854014
P/E ratio: 2.7000811871469095
Shares outstanding: 184927470
Book value: 6616795620.437956
P/B ratio: 1.2815367733074754
Market cap (USD): 8479666909.051094
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 0.09820528994559355
Free cash flow (dilution-adjusted): -6197810.218978101
Buyback yield (%): 0.025470977076860628
Retained earnings: 4590145985.40146
Capitalized R&D asset: 0
FCF margin (%): -2.9674772844414052
Revenue growth (%): -76.70969746133413
Rule of 40 score: -79.67717474577553
Financial ratios for CRDL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.85
Shares outstanding: 115272240
Market cap (USD): 213253644
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRDL — annual report dated 2022-12-31
Total revenue: 0
Operating income: -30394027.941176467
Net income: -22743122.794117644
Capital expenditures: 54933.08823529411
Operating cash flow: -20014959.55882353
Depreciation & amortization: 161697.0588235294
Net tangible assets: 38166754.4117647
Owner earnings: -22636358.823529407
Return on net tangible assets (%): -59.309100740700835
Buffett classification: The Gruesome
Stock price: 0.51
Shares outstanding: 115272240
Book value: 38383520.58823529
P/B ratio: 1.5316167328855974
Market cap (USD): 58788842.4
Debt to equity: 0.0013959537016383487
Current ratio: 6.266300209311923
Quick ratio: 6.266300209311923
Free cash flow (dilution-adjusted): -23756058.088235293
Buyback yield (%): 0
Retained earnings: -84153316.17647058
Receivables turnover: 0
Capitalized R&D asset: 13942705.88235294
ROCI (R&D-adjusted, %): -40.309125739524134
Rule of 40 score: 0
Financial ratios for CRDL — annual report dated 2023-12-31
Total revenue: 0
Operating income: -22564775.757575758
Net income: -21309312.12121212
Capital expenditures: 48721.21212121212
Operating cash flow: -19076091.666666664
Depreciation & amortization: 188147.72727272726
Net tangible assets: 21239506.818181816
Owner earnings: -21169885.606060605
Return on net tangible assets (%): -99.6722089042971
Buffett classification: The Gruesome
Stock price: 0.84
Shares outstanding: 115272240
Book value: 21398868.939393938
P/B ratio: 4.524943905878345
Market cap (USD): 96828681.6
Debt to equity: 0.0061720905880504095
Current ratio: 4.358173359456831
Quick ratio: 4.358173359456831
Free cash flow (dilution-adjusted): -22273875
Buyback yield (%): 0
Retained earnings: -108012728.78787878
Receivables turnover: 0
Capitalized R&D asset: 20117587.94117647
ROCI (R&D-adjusted, %): -48.10282730424231
Rule of 40 score: 0
Financial ratios for CRDL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 115272240
Market cap (USD): 228239035.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRDL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.28
Shares outstanding: 115272240
Market cap (USD): 147548467.20000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRDL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -28165490.20979021
Net income: -25648460.83916084
Capital expenditures: 14888.11188811189
Operating cash flow: -17525081.81818182
Depreciation & amortization: 260918.88111888114
Net tangible assets: 17292645.454545457
Owner earnings: -25402430.06993007
Return on net tangible assets (%): -146.8973046183221
Buffett classification: The Gruesome
Stock price: 1.28
Shares outstanding: 115272240
Book value: 17292645.454545453
P/B ratio: 8.532440428957976
Market cap (USD): 147548467.20000002
Debt to equity: 0.00641090680734439
Current ratio: 4.517733384024669
Quick ratio: 4.517733384024669
Free cash flow (dilution-adjusted): -27524169.93006993
Buyback yield (%): 0
Retained earnings: -125352518.18181819
Receivables turnover: 0
Capitalized R&D asset: 21619688.49886878
ROCI (R&D-adjusted, %): -76.59616145393629
Rule of 40 score: 0
Financial ratios for CRDL — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5894449.6503496505
Net income: -5795561.538461539
Capital expenditures: 8348.951048951049
Operating cash flow: -5002634.265734266
Depreciation & amortization: 17472.727272727272
Net tangible assets: 12299163.636363637
Owner earnings: -5786437.762237762
Return on net tangible assets (%): -47.04740853377715
Buffett classification: The Gruesome
Stock price: 0.97
Shares outstanding: 115272240
Book value: 12299163.636363637
P/B ratio: 9.09119319865061
Market cap (USD): 111814072.8
Debt to equity: 0.00856616323447771
Current ratio: 3.2606610281958375
Quick ratio: 3.2606610281958375
Free cash flow (dilution-adjusted): -5813062.937062938
Buyback yield (%): 0
Retained earnings: -131148079.72027972
Receivables turnover: 0
Capitalized R&D asset: 2627560.839160839
ROCI (R&D-adjusted, %): -27.603324271577335
Rule of 40 score: 0
Financial ratios for CRDL — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -5603035.03649635
Net income: -6098081.02189781
Capital expenditures: 4700
Operating cash flow: -3321586.8613138683
Depreciation & amortization: 18591.24087591241
Net tangible assets: 8618886.861313868
Owner earnings: -6084189.781021897
Return on net tangible assets (%): -70.59136381440352
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 115272240
Book value: 8618886.861313868
P/B ratio: 18.189152372293915
Market cap (USD): 156770246.4
Debt to equity: 0.012072790404708721
Current ratio: 2.464740603872002
Quick ratio: 2.464740603872002
Free cash flow (dilution-adjusted): -5180434.3065693425
Buyback yield (%): 0
Retained earnings: -142989872.26277372
Receivables turnover: 0
Capitalized R&D asset: 3754393.4994640397
ROCI (R&D-adjusted, %): -41.35768919034487
Rule of 40 score: 0
Financial ratios for CRDL — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -7323812.949640288
Net income: -7168547.482014389
Capital expenditures: 2171.223021582734
Operating cash flow: -4982022.302158274
Depreciation & amortization: 18382.01438848921
Net tangible assets: 6878327.338129497
Owner earnings: -7152336.690647482
Return on net tangible assets (%): -103.98366258318406
Buffett classification: The Gruesome
Stock price: 1.07
Shares outstanding: 115272240
Book value: 6878327.338129496
P/B ratio: 17.931873657170502
Market cap (USD): 123341296.80000001
Debt to equity: 0.014036267601030243
Current ratio: 3.8930622448818295
Quick ratio: 3.8930622448818295
Free cash flow (dilution-adjusted): -7861607.194244605
Buyback yield (%): 0
Retained earnings: -148132611.5107914
Receivables turnover: 0
Capitalized R&D asset: 5646607.955828711
ROCI (R&D-adjusted, %): -52.15269376406451
Rule of 40 score: 0